When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
The musician-turned-biotech-founder waiting to fundraise
Related Posts
Alibaba enters physical AI race with open-source robot model RynnBrain
Alibaba has entered the race to build AI that powers robots, not just chatbots. The Chinese tech giant…
DoorDash launches a new ‘Tasks’ app that pays couriers to submit videos to train AI
Delivery couriers will be able to earn money by completing activities like filming everyday tasks or recording themselves…
Trace raises $3M to solve the AI agent adoption problem in enterprise
Trace is launching with $3 million in seed funding, including investment from Y Combinator, Zeno Ventures, Transpose Platform Management,…